An integrated approach with vardenafil orodispersible tablet and cognitive behavioral sex therapy for treatment of erectile dysfunction: a randomized controlled pilot study

Erectile Dysfunction is considered a multifactorial disease, where organic and psychological aspects are often interconnected. In a randomized controlled pilot study, we compared the efficacy of combined vardenafil orodispersible tablet (VARD) and cognitive-behavioral sex therapy (CBST) vs.

VARD alone in improving sexual symptoms in both male and female partners. Thirty male patients with erectile dysfunction, and their partners were randomly assigned with a 2 : 1 ratio, to two different arms and treated for 10 weeks with VARD (Group A; n = 19) or VARD+CBST (Group B; n = 11). International Index of Erectile Dysfunction (IIEF-15), Female Sexual Function Index (FSFI) and Index of Sexual Satisfaction (ISS) were, respectively, administered to male, female, and both partners at times (T) 0, 1 (+5 weeks of therapy) and 2 (+10 weeks of therapy). Groups A and B were similar in their sociodemographic and clinical characteristics. Pre-treatment (T0) test scores did not significantly differ among the groups. In both group A and B, the IIEF-Erectile Function domain showed a significant improvement from T0 to T1 (p = 0.005 and p < 0.0001 vs. T0, respectively) and from T0 to T2 only in group B (p = 0.013). In group A, FSFI and both male and female ISS did not show any significant change at T1 and T2 vs. T0. In group B, a significant improvement at final time-point in FSFI and male and female ISS scores was reported (p < 0.05, T2 vs. T0 in all scores). The results of our study suggest that both VARD alone and VARD+CBST improved erectile function, however, only VARD+CBST improved couple sexual satisfaction and female sexual function. Andrology 2015 Sep [Epub]

V Boddi, G Castellini, H Casale, G Rastrelli, L Boni, G Corona, M Maggi

Andrology Unit, Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy , Psychiatry Unit, Department of Neurological and Psychiatric Sciences, University of Florence, Florence, Italy , Andrology Unit, Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy , Andrology Unit, Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy , Oncology Department, Careggi Hospital, Florence, Italy , Endocrinology Unit, Maggiore-Bellaria Hospital, Bologna, Italy , Andrology Unit, Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy

PubMed